Home > Search Results: Hachulla, Eric
  Search Tips
Advanced Search
Search collections:
Sort by: Display results: Output format:
Results overview: Found 2 records in 0.02 seconds.
Articles, 2 records found
Articles 2 records found  
1.
11 p, 784.4 KB Effectiveness and safety of tocilizumab in patients with systemic sclerosis : a propensity score matched controlled observational study of the EUSTAR cohort / Kuster, Simon (Department of Rheumatology. University Hospital Zurich. University of Zurich) ; Jordan, Suzana (Department of Rheumatology. University Hospital Zurich. University of Zurich) ; Elhai, Muriel (Department of Rheumatology. Paris Descartes University. Cochin Hospital. Aphp) ; Held, Ulrike (Department of Biostatistics at Epidemiology. Biostatistics and Prevention Institute. University of Zurich) ; Steigmiller, Klaus (Department of Biostatistics at Epidemiology. Biostatistics and Prevention Institute. University of Zurich) ; Bruni, Cosimo (Department of Experimental and Clinical Medicine. Division of Rheumatology. University of Florence) ; Cacciapaglia, Fabio (Rheumatology Unit. Deto. University Hospital Polyclinic of Bari) ; Vettori, Serena (Department of Precision Medicine. University of Campania Luigi Vanvitelli) ; Siegert, Elise (Berlin Institute of Health at Charité) ; Rednic, Simona (Clinica Reumatologie. University of Medicine and Pharmacy) ; Codullo, Veronica (Department of Rheumatology. Irccs Foundation Policlinico San Matteo) ; Airò, Paolo (Uoc Rheumatology and Clinical Immunology. Spedali Civili di Brescia) ; Braun-Moscovici, Yolanda (B. Shine Department of Rheumatology. Rambam Health Care Campus and Technion) ; Hunzelmann, Nicolas (University of Cologne) ; Joao Salvador, Maria (Department of Rheumatology. Centro Hospitalar e Universitário de Coimbra) ; Riccieri, Valeria (Department of Clinical Internal. Anesthesiological and Cardiovascular Sciences. Sapienza University of Rome) ; Gheorghiu, Ana-Maria (Department of Internal Medicine and Rheumatology. Cantacuzino Hospital. Carol Davila University of Medicine and Pharmacy) ; Alegre-Sancho, Juan José (Hospital Doctor Peset. Servicio de Reumatología) ; Romanowska-Prochnicka, Katarzyna (Department of Connective Tissues Diseases. Institute of Rheumatology) ; Castellvi, Ivan (Institut d'Investigació Biomèdica Sant Pau) ; Kötter, Ina (University Hospital Hamburg-Eppendorf. Division of Rheumatology and Systemic Inflammatory Diseases) ; Truchetet, Marie-Elise (Hospital General Universitario Gregorio Marañón) ; López-Longo, F.J. (Department of Rheumatology. National Reference Center for Systemic Autoimmune Rare Diseases. Hopital Pellegrin) ; Novikov, Pavel I. (Department of Rheumatology. National Reference Center for Systemic Autoimmune Rare Diseases. Hopital Pellegrin) ; Giollo, Alessandro (Rheumatology Section. Department of Medicine. University of Verona) ; Shirai, Yuichiro (Department of Allergy and Rheumatology. Nippon Medical School) ; Belloli, Laura (Rheumatology Unit. Asst Grande Ospedale Metropolitano Niguarda) ; Zanatta, Elisabetta (Rheumatology Unit. Department of Clinical and Experimental Medicine. University of Padova) ; Hachulla, Eric (Université de Lille) ; Smith, Vanessa (Unit for Molecular Immunology and Inflammation. Vib Inflammation Research Centre (IRC)) ; Denton, Christopher P. (Centre for Rheumatology. University College London Medical School. Royal Free Campus) ; Ionescu, Ruxandra M. (Internal Medicine and Rheumatology Department. St. Maria Hospital. Carol Davila University of Medicine and Pharmacy) ; Schmeiser, Tim (Krankenhaus St. Josef) ; Distler, Joerg H.W. (Department of Internal Medicine Iii. Erlangen University Hospital) ; Gabrielli, Armando (Dipartimento di Scienze Cliniche e Molecolari. Università Politecnica Delle Marche) ; Hoffmann-Vold, Anna-Maria (Department of Rheumatology. Rikshospitalet University Hospital Oslo) ; Kuwana, Masataka (Nippon Medical School Graduate School of Medicine) ; Allanore, Yannick (Department of Rheumatology. Paris Descartes University. Cochin Hospital. Aphp) ; Distler, Oliver (Department of Rheumatology. University Hospital Zurich. University of Zurich)
Objectives Tocilizumab showed trends for improving skin fibrosis and prevented progression of lung fibrosis in systemic sclerosis (SSc) in randomised controlled clinical trials. We aimed to assess safety and effectiveness of tocilizumab in a real-life setting using the European Scleroderma Trial and Research (EUSTAR) database. [...]
2022 - 10.1136/rmdopen-2022-002477
RMD Open, Vol. 8 Núm. 2 (march 2022) , p. e002477  
Detailed record - Creative Commons
2.
7 p, 556.8 KB Obstetrical outcome and treatments in seronegative primary APS : data from European retrospective study / Abisror, Noemie (Sorbonne Université) ; Nguyen, Yann (Paris University) ; Marozio, Luca (University of Torino) ; Esteve Valverde, Enrique (Althaia Network Health (Manresa)) ; Udry, Sebastian (Acute Hospital "Dr Carlos G Durand") ; Pleguezuelo, Daniel Enrique (Instituto de Investigación Sanitaria Hospital 12 de Octubre (i+12)) ; Billoir, Paul (Rouen University Hospital (França)) ; Mayer-Pickel, Karoline (Medical University of Graz) ; Urbanski, Geoffrey (CHU d'Angers) ; Zigon, Polona (University Medical Centre Ljubljana) ; De Moreuil, Claire (Université Bretagne Loire) ; Hoxha, Ariela (University of Padua) ; Bezanahary, Holy (University Hospital of Limoges) ; Carbillon, Lionel (Sorbonne University) ; Kayem, Gilles (Sorbonne Université) ; Bornes, Marie (Tenon Hospital) ; Yelnik, Cecile (Université de Lille) ; Johanet, Cathererine (Hôpital Saint Antoine) ; Nicaise-Roland, Pascale (Bichat Hospital) ; Lambert, Marc (Université de Lille) ; Salle, Valéry (University Hospital of Amiens) ; Latino, Omar Jose (Acute Hospital "Dr Carlos G Durand") ; Hachulla, Eric (Université de Lille) ; Benedetto, Chiara (University of Torino) ; Bourrienne, Marie Charlotte (Hôpital Bichat) ; Benhamou, Ygal (Rouen University Hospital (França)) ; Alijotas-Reig, Jaume (Universitat Autònoma de Barcelona. Departament de Medicina) ; Fain, Olivier (Sorbonne Université) ; Mekinian, Arsène (Sorbonne Université)
To compare characteristics, pregnancies and treatments during pregnancies of seronegative and seropositive antiphospholipid syndrome (APS), to analyse factors associated with obstetrical outcome. Inclusion criteria were: (1) thrombotic and/or obstetrical APS (Sydney criteria); (2) absence of conventional antiphospholipid antibodies (APL); (3) at least one persistent non-conventional APL among IgA anticardiolipin antibodies, IgA anti-B2GPI, anti-vimentin G/M, anti-annexin V G/M, anti-phosphatidylethanolamine G/M and anti-phosphatidylserine/prothrombin G/M antibodies. [...]
2020 - 10.1136/rmdopen-2020-001340
RMD Open, Vol. 6 (august 2020)  
Detailed record - Creative Commons

See also: similar author names
1 Hachulla, E.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.
UAB Digital Repository of Documents :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.6
Maintained by ddd.bib@uab.cat  :: Metadata license:
Working with